Drug intelligence / Profile preview

celecoxib + dexamethasone + dextromethorphan + gabapentin + ondansetron + paracetamol

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal
01

Overview

This is a combination of six different medications, each with distinct mechanisms of action: - **Celecoxib**: A selective cyclooxygenase-2 (COX-2) inhibitor and nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation with reduced risk of gastrointestinal bleeding compared to other NSAIDs. - **Dexamethasone**: A corticosteroid that works on the immune system to help relieve swelling, inflammation, and allergic reactions. - **Dextromethorphan**: A cough suppressant that affects signals in the brain that trigger the cough reflex. - **Gabapentin**: An anticonvulsant and nerve pain medication that works by affecting chemicals and nerves in the body that are involved in seizures and pain. - **Ondansetron**: A serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting. - **Paracetamol** (Acetaminophen): A non-opioid analgesic and antipyretic that reduces pain and fever by inhibiting prostaglandin production. This multi-drug combination may be used for complex pain management scenarios requiring anti-inflammatory, corticosteroid, neuropathic pain, and anti-emetic effects simultaneously.

02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GR (Glucocorticoid receptor)SERT (Sodium-dependent serotonin transporter)SIGMAR1 (Sigma non-opioid intracellular receptor 1)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)CACNA2D2 (α2δ-2)NMDAR (Glutamate receptor ionotropic, NMDA)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on celecoxib + dexamethasone + dextromethorphan + gabapentin + ondansetron + paracetamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on celecoxib + dexamethasone + dextromethorphan + gabapentin + ondansetron + paracetamol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call